LEADER 02144nas  2200661-  450 
001 9910725983903321
005 20240116213021.0
011   $a2380-8993
035   $a(OCoLC)921248203
035   $a(CKB)3710000000631159
035   $a(CONSER)--2015203360
035   $a(DE-599)ZDB2870422-8
035   $a(EXLCZ)993710000000631159
100   $a20150916a20169999  ---            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExpert review of precision medicine and drug development
210  1$aAbingdon, Oxon, UK :$cTaylor & Francis Group,$d2016-
300   $aRefereed/Peer-reviewed
531 0 $aExpert rev. precis. med. drug dev.
531 10$aExpert Rev Precis Med Drug Dev
606   $aPrecision medicine$vPeriodicals
606   $aDrug development$vPeriodicals
606   $aPharmacogenetics$vPeriodicals
606   $aBiochemical markers$vPeriodicals
606   $aPrecision Medicine
606   $aBiomarkers$xanalysis
606   $aClinical Laboratory Techniques$xstandards
606   $aPharmacogenetics
606   $aDrug Design
606   $aBiochemical markers$2fast$3(OCoLC)fst00831950
606   $aDrug development$2fast$3(OCoLC)fst00898670
606   $aPrecision medicine$2fast$3(OCoLC)fst01910010
606   $aPharmacogenetics$2fast$3(OCoLC)fst01060243
608   $aPeriodical.
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
615  0$aPrecision medicine
615  0$aDrug development
615  0$aPharmacogenetics
615  0$aBiochemical markers
615 12$aPrecision Medicine.
615  2$aBiomarkers$xanalysis.
615  2$aClinical Laboratory Techniques$xstandards.
615  2$aPharmacogenetics.
615 22$aDrug Design.
615  7$aBiochemical markers.
615  7$aDrug development.
615  7$aPrecision medicine.
615  7$aPharmacogenetics.
676   $a610
906   $aJOURNAL
912   $a9910725983903321
996   $aExpert review of precision medicine and drug development$93375237
997   $aUNINA